Martin James Joseph 4
4 · Cocrystal Pharma, Inc. · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Martin James Joseph
Co-CEO and CFO
Transactions
- Award
Common Stock
2025-10-28$1.39/sh+3,598$5,001→ 44,167 total - Award
Warrants
2025-10-28$1.39/sh+7,196$10,002→ 7,196 totalExercise: $1.24Exp: 2028-01-28→ Common Stock (7,196 underlying)
Footnotes (2)
- [F1]The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock. The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance.
- [F2]Includes shares of common stock issuable upon vesting of restricted stock units.